REVELATION BIOSCIENCES, INC. (REVB) — Institutional Holders, Q2 2026
13 institutional investment managers reported a REVB position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $313.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
REVB in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- SABBY MANAGEMENTAdded · +111,150 sh+$114.5K
- CITADEL ADVISORSNew · +38,579 sh+$39.7K
- HRT FINANCIALNew · +16,978 sh+$17.5K
- Tower Research Capital (TRC)Added · +2,454 sh+$2.5K
- BARCLAYS PLCNew · +168 sh+$173.00
Biggest sellers
- ARMISTICE CAPITALSold out · -323,241 sh-$332.9K
- GEODE CAPITAL MANAGEMENTTrimmed · -26,003 sh-$26.8K
- XTX Topco LtdSold out · -11,385 sh-$11.7K
- UBS Group AGSold out · -4,115 sh-$4.2K
REVB 13F holders ranked 1–13 of 13
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | SABBY MANAGEMENT#1 · 210,582 sh | 210,582 | $216.9K | 0.20% | +111.8% |
| 2 | CITADEL ADVISORS#2 · 38,579 sh | 38,579 | $39.7K | 0.00% | New |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 17,192 sh | 17,192 | $17.7K | 0.00% | -60.2% |
| 4 | HRT FINANCIAL#4 · 16,978 sh | 16,978 | $17.0K | 0.00% | New |
| 5 | VANGUARD FIDUCIARY#5 · 13,127 sh | 13,127 | $13.5K | 0.00% | 0.0% |
| 6 | Tower Research Capital (TRC)#6 · 6,528 sh | 6,528 | $6.7K | <0.01% | +60.2% |
| 7 | ROYAL BANK OF CANADA#7 · 747 sh | 747 | $1.0K | 0.00% | 0.0% |
| 8 | SBI Securities , Ltd.#8 · 344 sh | 344 | $354.00 | — | 0.0% |
| 9 | BARCLAYS PLC#9 · 168 sh | 168 | $173.00 | 0.00% | New |
| 10 | HARBOUR INVESTMENTS#10 · 41 sh | 41 | $42.00 | 0.00% | 0.0% |
| 11 | BNP Paribas Asset Management Holding S.A.#11 · 9 sh | 9 | $9.00 | 0.00% | 0.0% |
| 12 | Caitong International Asset Management , Ltd#12 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
| 13 | FMR#13 · 0 sh | 0 | $0.00 | 0.00% | New |
Funds that sold out of REVB in Q2 2026 (3)
Held REVB at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| ARMISTICE CAPITAL323,241 sh | 323,241 | $387.9K |
| XTX Topco Ltd11,385 sh | 11,385 | $13.7K |
| UBS Group AG4,115 sh | 4,115 | $4.9K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.